MDNews - Central New York

November/December 2017

Issue link: https://viewer.e-digitaledition.com/i/891967

Contents of this Issue

Navigation

Page 7 of 23

Screenings, such as low-dose CT scans used to detect lung cancer, help qualify patients for clinical trials and connect them with leading-edge procedures earlier in the disease cycle. " We are identifying more cancers at earlier stages in the screened population, shifting the curve from stage 3 and 4 to the more treatable and curable stages 1 and 2," Dr. Wa llen says. "I want as many patients as possible to have the option of surgery. At Upstate Cancer Center, we can perform most lung cancer procedures in a minimally invasive fashion, often using a robotic-assisted procedure. As we shift more patients to surger y, those patients will not require chemotherapy or immunotherapy." PERSONALIZED CARE Taking a patient-specific, patient-centered approach is vital to treatment at Upstate Cancer Center. This includes medicine tailored to the patient's tumor and o„ering a wide range of treatment options to each patient. Lisa Lai, MD, Assistant Professor of Surgery and Medical Director of the Breast Cancer Program, is a fellowship-trained breast surgeon with a practice devoted exclusively to the treat- ment of breast disease. She guides each of her patients through the many choices available to women and men with breast cancer. "We take many things into consideration — the breast cancer subtype and stage, the patient's age and overall health, their Lawrence Chin, MD, Chair of Neurosurgery Lisa Lai, MD, Assistant Professor of Surgery and Medical Director of the Breast Cancer Program 0 8C O V E R S T O R Y Gennady Bratslavsky, MD, Professor and Chair of the Department of Urology at Upstate Medical Center, speaks with a patient.

Articles in this issue

Archives of this issue

view archives of MDNews - Central New York - November/December 2017